Article information
Full text is only aviable in PDF
References
[1.]
J. Braun, M. Bollow, G. Remlinger, U. Eggens, M. Rudwaleit, A. Distler, et al.
Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.
Arthritis Rheum, 41 (1998), pp. 58-67
[2.]
J. Braun, J. Sieper.
The sacroiliac joint in the spondyloarthropathies.
Curr Opin Rheumatol, 8 (1996), pp. 275-287
[3.]
J. Braun, M. Bollow, J. Sieper.
Radiology and pathology of the spondyloarthropathies.
Rheum Dis Clin North Am, 24 (1998), pp. 697-735
[5.]
S. Langlois, J.P. Cedoz, A. Lohse, E. Toussirot, D. Wendling.
Aseptic discitis in patients with ankylosing spondylitis: a retrspective study of 14 cases.
Joint Bone Spine, 72 (2005), pp. 248-253
[6.]
B. Roychowdhury, S. Bintley-Bagot, D.Y. Bulgen, R.N. Thompson, E.J. Tunn, R.J. Moots.
Is methotrexate effective in ankylosing spondylitis?.
Rheumatology (Oxford), 41 (2002), pp. 1330-1332
[7.]
J. Braun, R. Alten, G. Burmester, W. Ebner, B. Gommor, K. Grasedyck, et al.
Efficacy of sulfasalazine in undifferentiated spondyloarthritis and eraly ankylosing spondylitis: a multicenter randomized controlled trial.
Annual European Congress of Rheumtology, (2004),
[8.]
J. Brandt, A. Khariouzov, J. Listing, H. Haibel, H. Sorensen, L. Grassnickel, et al.
Six-month results of a double-blind, placebo-controlled trial etanercept treatment in patients with active ankylosing spondylitis.
Arthritis Rheum, 48 (2003), pp. 1667-1675
[9.]
J. Davis, D. van der Heijide, J. Braun, M. Dougados, J. Cush, D.O. Clegg, et al.
One year efficacy of etanercept in ankylosing spondylitis [abstract].
Ann Rheum Dis, 63 (2004), pp. 390
[10.]
X. Baraliakos, J. Brandt, J. Listing, H. Haibel, H. Sorensen, M. Rudwaleit, et al.
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
Arthritis Rheum, 53 (2005), pp. 856-863
[11.]
M. Rudwaleit, X. Baraliakos, J. Listing, J. Brandt, J. Sieper, J. Braun.
Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
Ann Rheum Dis, 64 (2005), pp. 1305-1310
[12.]
X. Baraliakos, J. Davis, W. Tsuji, J. Braun.
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept.
Arthritis Rheum, 52 (2005), pp. 1216-1223
[13.]
X. Baraliakos, A. Wanders, J. Listing, J. Brandt, M. Rudwaleit, J. Sieper, et al.
X–ray progression in patients with ankylosing spondylitis (AS) afeter 2 years of infliximab therapy [Abstract].
Arthritis Rheum, 50 (2004), pp. S450
Copyright © 2008. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
